Table 3 Primary diagnosis and prevalence of causative Candida species
Characteristic | Micafungin | Liposomal amphotericin B | Total | |||
|---|---|---|---|---|---|---|
| Â | Non-ICU (n = 127) | ICU (n = 120) | Non-ICU (n = 136) | ICU (n = 110) | Non-ICU (n = 263) | ICU (n = 230) |
Primary diagnosis | Â | Â | Â | Â | Â | Â |
   Candidemia | 109 (85.8) | 98 (81.7) | 115 (84.6) | 94 (85.5) | 224 (85.2) | 192 (83.5) |
   Invasive candidiasis | 18 (14.2) | 22 (18.3) | 21 (15.4) | 16 (14.5) | 39 (14.8) | 38 (16.5) |
Isolated Candida spp. at baselinea | ||||||
   Candida albicans | 44 (34.6) | 58 (48.3) | 55 (40.4) | 54 (49.1) | 99 (37.6) | 112 (48.7) |
   Candida parapsilosis | 29 (22.8) | 13 (10.8) | 22 (16.2) | 16 (14.5) | 51 (19.4) | 29 (12.6) |
   Candida tropicalis | 37 (29.1) | 29 (24.2) | 36 (26.5) | 26 (23.6) | 73 (27.8) | 55 (23.9) |
   Candida glabrata | 15 (11.8) | 15 (12.5) | 10 (7.4) | 9 (8.2) | 25 (9.5) | 24 (10.4) |
   Candida krusei | 5 (3.9) | 4 (3.3) | 9 (6.6) | 1 (0.9) | 14 (5.3) | 5 (2.2) |
   Other Candida species | 6 (4.7) | 11 (9.2) | 17 (12.5) | 14 (12.7) | 23 (8.7) | 25 (10.9) |